Related Experiment Video
Updated: Jan 10, 2026

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein
Published on: March 9, 2015
CFTR correctors potentiate gating mutants causing cystic fibrosis
Solène Castanier1, Ahmad Elbahnsi2, Benoit Chevalier1
1Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades F-75015 Paris, France.
The CFTR modulator VX-445 (Elexacaftor) enhances channel activity in cystic fibrosis gating mutants. Its potentiator effect depends on the binding site integrity, but other correctors also show this capability.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Cystic Fibrosis Transmembrane conductance Regulator (CFTR) modulators like VX-445 (Elexacaftor) are crucial for cystic fibrosis (CF) treatment.
- VX-445 exhibits both corrector and potentiator activities by binding to the CFTR protein.
- Previous studies linked VX-445 corrector activity to mutations in MSD1 and NBD1.
Purpose of the Study:
- To investigate whether mutations affecting VX-445's corrector activity also impact its potentiator function.
- To determine the relationship between VX-445 binding site integrity and its potentiator effects on CFTR gating mutants.
Main Methods:
- HEK293 cells were transfected with CFTR mutants.
- Halide-sensitive fluorescent assays measured responses to varying VX-445 concentrations.
- Mutations within and outside the VX-445 binding site were analyzed.
Main Results:
- VX-445 potentiated gating mutants in NBDs (G551D, G1349D) and ICLs (G178R, G970R).
- Mutations in the VX-445 binding site reduced potentiation of G551D.
- Mutations outside the binding site affected corrector activity, with M212A and F224A inducing CFTR gain-of-function.
- VX-809 and VX-121 also potentiated G551D.
Conclusions:
- VX-445 promotes channel activity in CFTR gating mutants, contingent on its binding site's structural integrity.
- CFTR correctors, including VX-809 and VX-121, can generally enhance channel activity of gating mutants.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
GPCRs Regulate Adenylyl Cylase Activity
Genome Copying Errors
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Mutations

